These findings support the use of abiraterone acetate plus prednisone as a standard of care in patients with highrisk mcspc. Zytiga is contraindicated in women who are or may become pregnant. Abiraterone acetates safety profile makes it well suited to combine with. The process is characterised by an intermediate step wherein dheaacetate. Clinical trials using abiraterone acetate national. The rationale for that claim also makes little sense. Specifically it is used together with corticosteroid for metastatic castrationresistant prostate cancer mcrpc and metastatic highrisk castrationsensitive prostate cancer mcspc. Abiraterone is a steroidal compound with antiandrogen activity. Clinical trials using abiraterone acetate national cancer.
Abiraterone delays metastatic prostate cancer growth. Abiraterone acetate is available in the form of tablets, in two different doses 250 mg and 500 mg. Abiraterone acetate, a drug that blocks endogenous androgen synthesis, plus prednisone is indicated for metastatic castrationresistant prostate cancer. Abiraterone plus prednisone in metastatic, castration. Qualitative and quantitative composition zytiga tablets contain either 250 mg or 500 mg of abiraterone acetate. Abiraterone for prostate cancer not previously treated. Abiraterone for treating metastatic hormonerelapsed prostate.
Know abiraterone uses, side effects, dosage, contraindications, benefit, interactions, purpose, drug interactions, precautions, warnings only. Treatment with abiraterone acetate in men with crpc leads to a profound depletion of serum adrenal androgens and frequent declines in psa 6973. Abiraterone acetate zytiga is a type of hormone therapy for men with prostate cancer that has spread to other parts of the body advanced prostate cancer. The process is characterized by an intermediate step wherein dheaacetate. Abiraterone acetate is poised to challenge docetaxel as the standard addition to androgen deprivation therapy for treatment of newly diagnosed. Horsham, pa april 28, 2011 centocor ortho biotech inc. Abiraterone acetate aa, after metabolization to abiraterone, is an oral inhibitor of the cytochrome p450c17. Abiraterone acetate aa is a selective inhibitor of cytochrom p450 cyp17 which is required for androgen biosynthesis, and can block the androgens synthesis by testicles, surrenals and. Australian public assessment report for abiraterone acetate. We report the case of a 64yearold patient with ductal adenocarcinoma of the prostate, which progresses to castrationresistant prostate cancer, that was treated with abiraterone acetate with good clinical response, to our knowledge, the first case of ductal adenocarcinoma of the prostate in treatment with abiraterone acetate. In large phase 3 trials and in the clinical practice setting, oral abiraterone acetate in.
The drug information on this page is meant to be educational. All trials on the list are supported by nci ncis basic information about clinical trials explains the types and phases of trials and how they are carried out. Abiraterone inhibits the enzymatic activity of steroid 17alphamonooxygenase 17alphahydrolasec17,20 lyase complex. Its molecular formula is c26h33no2 and it has a molecular weight of 391. Abiraterone acetate is a selective, irreversible inhibitor of cyp17, an enzyme that is critical in the. The goal of couaa301 this trial is to demonstrate a clinical benefit of abiraterone for this clinical scenario. After an oral dose, 88% of the administered drug is recovered in feces, mostly as unchanged abiraterone acetate.
Ncis basic information about clinical trials explains the types and phases of trials and how they are carried out. For patients who resume therapy, monitor serum transaminases and bilirubin at a minimum of every 2 weeks for 3 months and monthly thereafter. Differences in clinical outcome between docetaxel and abiraterone. New abiraterone acetate formulation approved by fda for mcrpc.
Abiraterone acetate is a potent inhibitor of both 17. Abiraterone is administered as an acetate salt prodrug because it has a higher bioavailability and less susceptible to hydrolysis than abiraterone itself. No food should be eaten for at least two hours before the dose of zytiga is taken and for at least one hour after the dose of zytiga is taken. I propose that this abiraterone acetate be merged with abiraterone. Pdf impact of abiraterone acetate plus prednisone or. Abiraterone was found to be more than 99% bound to albumin and alpha 1acid glycoprotein. List of drug master files dmf of abiraterone acetate active pharmaceutical ingredient api submitted to the u.
Exposure of abiraterone increases up to 10fold when abiraterone acetate is taken with meals. Abiraterone acetate is a white to offwhite, nonhygroscopic, crystalline powder. Pdf abiraterone acetate for the treatment of chemotherapy. Read the patient information leaflet if available from your pharmacist before you start taking abiraterone and each time you get a refill. Abiraterone acetate was initially approved in the united states in 2011 after. Abiraterone, also known as abiraterone acetate and sold under the brand name zytiga among others, is a medication used to treat prostate cancer. The retention time of the major peak of the sample solution corresponds to that of the standard solution, as obtained in the assay. Clinical trials are research studies that involve people. Cost effectiveness of abiraterone acetate zytiga for. Abiraterone acetate inhibits the synthesis of the natural ligands of the. Abiraterone acetate for metastatic castrationresistant prostate. What do we know about treatment sequencing of abiraterone.
The clinical trials on this list are studying abiraterone acetate. Cyp17 enzyme inhibition reduces the conversion of pregnenolone and. Pdf introduction abiraterone acetate plus prednisone aap and. Ongoing androgen deprivation with a testosterone level50. In some cases, health care professionals may use the trade name zytiga when referring to the generic drug name abiraterone acetate. Abiraterone acetate api dmfs us drug master file dmf. Aa 1 g daily plus prednisone or prednisolone 5 mg twice daily is approved for the treatment of patients with mcrpc on the basis of results for two. Abiraterone acetate is poised to challenge docetaxel as the standard addition to androgen deprivation therapy for treatment of newly diagnosed, metastatic castrationresistant prostate cancer.
Os and progressionfree survival pfs were the key clinical inputs for the economic submission. Dailymed abiraterone acetate tablet abiraterone acetate. Abido the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Its molecular formula is c 26 h 33 no 2 and it has a molecular weight of 391. Abiraterone acetate for metastatic castrationa wiley online library. Zytiga abiraterone acetate receives fda approval for. Find clinical trials for abiraterone acetate check for trials from ncis list of cancer clinical trials now accepting patients. Chicago adding abiraterone acetate zytiga plus prednisone to standard hormonal therapy for men newly diagnosed with highrisk, metastatic prostate cancer lowers the chance of death by 38%. The combination of abiraterone acetate plus prednisone with adt was associated with significantly longer overall survival than placebos plus adt in men with newly diagnosed highrisk mcspc and had a manageable safety profile. Abiraterone acetate is a lipophilic compound with an octanolwater partition coefficient of 5.
It is usually only offered to men whose cancer has stopped responding to other types of hormone therapy you may hear this called secondline therapy. Abiraterone acetate in combination with docetaxel after disease progression to abiraterone acetate in metastatic castration resistant prostate cancer. Abiraterone acetateprednisone treatment significantly decreased prostate specific. Cyp17a1, a member of the cytochrome p450 family that catalyzes the 17alphahydroxylation of steroid intermediates involved in testosterone synthesis. A new formulation of abiraterone acetate yonsa in combination with methylprednisolone has been approved by the fda as a treatment for men with metastatic castrationresistant prostate cancer mcrpc, according to sun pharma, the company commercializing the treatment.
Abiraterone improves survival in metastatic prostate cancer. Abiraterone acetate is converted, in vivo, to abiraterone, which selectively inhibits the cyp17 enzyme in testicular, adrenal and prostate tumour tissues. Jan 14, 2014 abiraterone acetate in combination with docetaxel after disease progression to abiraterone acetate in metastatic castration resistant prostate cancer. Abiraterone acetate aa is a prodrug of abiraterone, a potent and specific inhibitor of the enzyme 17. The mean halflife of abiraterone in crpc patients is 12 5 hours. Abiraterone acetate is taken at least two hours after a meal and at least one hour before eating anything else. Abiraterone acetate tablets definition abiraterone acetate tablets contain nlt 90. This study aimed to compare the efficacy of abiraterone acetate aa versus docetaxel t as firstline treatment.
Zytiga abiraterone acetate 250 mg tablets are white to offwhite, ovalshaped tablets debossed with aa250 on one side. Success of abiraterone trials prompts mind shift in. Structure, properties, spectra, suppliers and links for. Extract from the clinical evaluation report for abiraterone acetate proprietary product name. Because cabazitaxel has a survival benefit compared with best supportive care, but is not recommended in nices technology appraisal on cabazitaxel for hormonerefractory metastatic prostate cancer previously treated with a docetaxelcontaining regimen, the company adjusted postdocetaxel. Janssen submits additional marketing applications for zytiga. Abiraterone plus prednisone in metastatic, castrationsensitive prostate cancer june 4, 2017 background. Aug 17, 2017 oral abiraterone acetate zytiga is a selective inhibitor of cyp17 and thereby inhibits androgen biosynthesis, with androgen signalling crucial in the progression from primary to metastatic prostate cancer pc and subsequently, in the development of metastatic castrationresistant pc mcrpc.
Submission pm20120270634 extract from the clinical evaluation report for zytiga page 7 of 38 therapeutic goods administration to establish additional clinically relevant improvements in prostate cancer subjects treated. Clinical trials look at new ways to prevent, detect, or. Des discrete event simulation, aap abiraterone acetate in combination with prednisone. Monitor patients with cardiovascular disease closely, particularly those with heart failure, recent mi, or ventricular arrhythmia. Janssen submits additional marketing applications for. Abiraterone is a derivative of steroidal progesterone and is an innovative drug that offers clinical benefit to patients with hormone refractory prostate cancer. Abiraterone zytiga, a novel agent for the management of. Get verified listings of abiraterone acetate cas no 154229182 manufacturers, suppliers and exporters. Clinical trials look at new ways to prevent, detect, or treat disease.
The present invention relates to a novel process for the synthesis of abiraterone, and in particular of abiraterone acetate, compound of formula i reported below. Food and drug administration fda has approved zytiga abiraterone acetate, an oral, oncedaily medication for use in combination with prednisone for the treatment of men with metastatic castrationresistant prostate cancer who have received prior chemotherapy containing docetaxel. Abiraterone acetate and castration resistant ductal. Us9650410b2 process for the preparation of abiraterone. Pdf oral formulation strategies to improve the bioavailability and. Abiraterone is an anticancer drug used in men along with another drug called prednisone for the treatment of prostate cancer that has spread to other parts of the body. N o i which has pharmacological activity useful tor slowing down the progression of prostate cancer at an advanced stage. Abiraterone acetate zytiga for the treatment of metastatic. Subsequent chemotherapy and treatment patterns after. Abiraterone is a type of hormone therapy for cancer that has spread beyond the prostate to other parts of the body metastatic prostate cancer.
Evidence acquisition on therapeutic sequences in mcrpc was performed by a medline search using combination of the following key words. Wo2015015246a1 process for the preparation of abiraterone. Product name zytiga 250 mg tablets zytiga 500 mg filmcoated tablets 2. Cost effectiveness of abiraterone acetate zytiga for the. In a phase iii clinical trial of 1,200 men, abiraterone also more than doubled the median time until the cancer worsened, from 14.
N o i which has pharmacological activity useful for slowing down the progression of prostate cancer at an advanced stage. This medication is classified as an adrenal inhibitor. Abiraterone acetate affects prostate, testicular, and adrenal androgens by irreversibly inhibiting both the lyase and hydroxylase activity of cytochrome p450 17a cyp17 signaling pathways ic 50s of 2. Treatment sequencing in metastatic castrateresistant. Abiraterone acetate plus prednisone in patients with newly. Crossresistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castrationresistant prostate cancer. Abiraterone, also known as abiraterone acetate and sold under the brand name zytiga among. Submission pm20120270634 extract from the clinical evaluation report for zytiga page 3 of 38. A new formulation of abiraterone acetate in combination with methylprednisolone has been approved by the fda as a treatment for men with metastatic castrationresistant prostate cancer, according to sun pharma, the company commercializing the treatment. Abiraterone mg once daily in combination with prednisone or. The incremental benefits of abiraterone were generated from the third interim couaa302 trial data. Abiraterone acetate clinical trial of a cellular hormone. Abiraterone acetate is the generic name for the trade name drug zytiga. In our opinion, it could be possible to combine enzalutamide with.
Abiraterone and increased survival in metastatic prostate cancer for the couaa301 investigators. We evaluated the clinical benefit of abiraterone acetate plus prednisone with androgendeprivation therapy in patients with newly diagnosed, metastatic, castrationsensitive prostate cancer. Abiraterone acetate is a semisynthetic steroid with multiple chiral centres figure 1, all of which are controlled so that abiraterone acetate is a single stereoisomer. Ccds 190424 1 zytiga190715 ads zytiga abiraterone acetate new zealand data sheet 1. Zytiga can cause fetal harm when administered to a pregnant woman. Pdf abiraterone acetate, marketed as zytiga, is an antiandrogen. Abiraterone acetate manufacturers, suppliers and exporters. Interrupt therapy, then restart at a reduced dose of 375 mg orally once a day following return of liver function tests to baseline or to alt and ast 2. Abiraterone acetate in combination with docetaxel after.
It is generally used in patients who are not responding to other treatment options. These shown companies are providing abiraterone acetate as per industry standards. It is a tablet taken once a day in combination with a steroid drug prednisolone or prednisone, which reduces inflammation. Abiraterone acetate in the treatment of metastatic castrationresistant.
364 677 785 1214 1201 376 534 45 925 237 550 1521 1058 1203 1647 1604 935 697 417 1321 731 1413 362 181 300 980 59 1006 1600 69 520 1158 1272 1142 792 1037 875 208